The metabolic syndrome and cardiovascular disease: Part 2

Panupong Jiamsripong, Martina Mookadam, Mohsen S. Alharthi, Bijoy K. Khandheria, Farouk Mookadam

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In part 1 of this overview, the authors reviewed the epidemiology, definitions, pathophysiology, and interaction of inflammatory markers that are elaborated from the very active paracrine adipocyte. In part 2, they focus on the management of the metabolic syndrome. Management of this syndrome includes identification of individuals in the early stages of the syndrome and emphasizes the risk of developing diabetes mellitus and the progression to cardiovascular disease. This can be accomplished by simple physical examination and an assessment of routine laboratory findings, which should include measurement of fasting glucose, a lipid profile, and body morphometrics. A 10-year risk assessment is needed in patients who have a diagnosis of the metabolic syndrome. The most important therapeutic intervention in the metabolic syndrome is lifestyle change, with a focus on weight reduction and regular leisure time physical activity.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalPreventive Cardiology
Volume11
Issue number4
DOIs
StatePublished - 2008

Fingerprint

Metabolic Diseases
Cardiovascular Diseases
Leisure Activities
Adipocytes
Physical Examination
Life Style
Weight Loss
Fasting
Diabetes Mellitus
Epidemiology
Exercise
Lipids
Glucose

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Public Health, Environmental and Occupational Health

Cite this

Jiamsripong, P., Mookadam, M., Alharthi, M. S., Khandheria, B. K., & Mookadam, F. (2008). The metabolic syndrome and cardiovascular disease: Part 2. Preventive Cardiology, 11(4), 223-229. https://doi.org/10.1111/j.1751-7141.2008.00002.x

The metabolic syndrome and cardiovascular disease : Part 2. / Jiamsripong, Panupong; Mookadam, Martina; Alharthi, Mohsen S.; Khandheria, Bijoy K.; Mookadam, Farouk.

In: Preventive Cardiology, Vol. 11, No. 4, 2008, p. 223-229.

Research output: Contribution to journalArticle

Jiamsripong, P, Mookadam, M, Alharthi, MS, Khandheria, BK & Mookadam, F 2008, 'The metabolic syndrome and cardiovascular disease: Part 2', Preventive Cardiology, vol. 11, no. 4, pp. 223-229. https://doi.org/10.1111/j.1751-7141.2008.00002.x
Jiamsripong P, Mookadam M, Alharthi MS, Khandheria BK, Mookadam F. The metabolic syndrome and cardiovascular disease: Part 2. Preventive Cardiology. 2008;11(4):223-229. https://doi.org/10.1111/j.1751-7141.2008.00002.x
Jiamsripong, Panupong ; Mookadam, Martina ; Alharthi, Mohsen S. ; Khandheria, Bijoy K. ; Mookadam, Farouk. / The metabolic syndrome and cardiovascular disease : Part 2. In: Preventive Cardiology. 2008 ; Vol. 11, No. 4. pp. 223-229.
@article{66e5069d4d644463942dbd2797bea004,
title = "The metabolic syndrome and cardiovascular disease: Part 2",
abstract = "In part 1 of this overview, the authors reviewed the epidemiology, definitions, pathophysiology, and interaction of inflammatory markers that are elaborated from the very active paracrine adipocyte. In part 2, they focus on the management of the metabolic syndrome. Management of this syndrome includes identification of individuals in the early stages of the syndrome and emphasizes the risk of developing diabetes mellitus and the progression to cardiovascular disease. This can be accomplished by simple physical examination and an assessment of routine laboratory findings, which should include measurement of fasting glucose, a lipid profile, and body morphometrics. A 10-year risk assessment is needed in patients who have a diagnosis of the metabolic syndrome. The most important therapeutic intervention in the metabolic syndrome is lifestyle change, with a focus on weight reduction and regular leisure time physical activity.",
author = "Panupong Jiamsripong and Martina Mookadam and Alharthi, {Mohsen S.} and Khandheria, {Bijoy K.} and Farouk Mookadam",
year = "2008",
doi = "10.1111/j.1751-7141.2008.00002.x",
language = "English (US)",
volume = "11",
pages = "223--229",
journal = "Preventive Cardiology",
issn = "1520-037X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The metabolic syndrome and cardiovascular disease

T2 - Part 2

AU - Jiamsripong, Panupong

AU - Mookadam, Martina

AU - Alharthi, Mohsen S.

AU - Khandheria, Bijoy K.

AU - Mookadam, Farouk

PY - 2008

Y1 - 2008

N2 - In part 1 of this overview, the authors reviewed the epidemiology, definitions, pathophysiology, and interaction of inflammatory markers that are elaborated from the very active paracrine adipocyte. In part 2, they focus on the management of the metabolic syndrome. Management of this syndrome includes identification of individuals in the early stages of the syndrome and emphasizes the risk of developing diabetes mellitus and the progression to cardiovascular disease. This can be accomplished by simple physical examination and an assessment of routine laboratory findings, which should include measurement of fasting glucose, a lipid profile, and body morphometrics. A 10-year risk assessment is needed in patients who have a diagnosis of the metabolic syndrome. The most important therapeutic intervention in the metabolic syndrome is lifestyle change, with a focus on weight reduction and regular leisure time physical activity.

AB - In part 1 of this overview, the authors reviewed the epidemiology, definitions, pathophysiology, and interaction of inflammatory markers that are elaborated from the very active paracrine adipocyte. In part 2, they focus on the management of the metabolic syndrome. Management of this syndrome includes identification of individuals in the early stages of the syndrome and emphasizes the risk of developing diabetes mellitus and the progression to cardiovascular disease. This can be accomplished by simple physical examination and an assessment of routine laboratory findings, which should include measurement of fasting glucose, a lipid profile, and body morphometrics. A 10-year risk assessment is needed in patients who have a diagnosis of the metabolic syndrome. The most important therapeutic intervention in the metabolic syndrome is lifestyle change, with a focus on weight reduction and regular leisure time physical activity.

UR - http://www.scopus.com/inward/record.url?scp=66949175549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66949175549&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7141.2008.00002.x

DO - 10.1111/j.1751-7141.2008.00002.x

M3 - Article

C2 - 19476575

AN - SCOPUS:66949175549

VL - 11

SP - 223

EP - 229

JO - Preventive Cardiology

JF - Preventive Cardiology

SN - 1520-037X

IS - 4

ER -